These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9041157)

  • 1. A strong prognostic variable in endometrial carcinoma: flow cytometric S-phase fraction.
    Kaleli S; Kösebay D; Beşe T; Demirkiran F; Oz UA; Arvas M; Aydinli K; Erkün E
    Cancer; 1997 Mar; 79(5):944-51. PubMed ID: 9041157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II.
    Wagenius G; Bergström R; Strang P; Gerdes U; Rogo K; Tribukait B; Stendahl U
    Anticancer Res; 1992; 12(3):725-32. PubMed ID: 1622130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
    Green RW; Engblom S; Baldetorp B; Hartman L; Måsbäck A; Bjurberg M
    Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1064-73. PubMed ID: 26123703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
    Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
    Santala M; Talvensaari-Mattila A
    Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.
    Silverman MB; Roche PC; Kho RM; Keeney GL; Li H; Podratz KC
    Gynecol Oncol; 2000 Apr; 77(1):1-7. PubMed ID: 10739683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
    J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of cell kinetics in endometrial adenocarcinoma.
    Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
    Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma.
    Lindahl B; Willén R
    Anticancer Res; 1998; 18(6B):4611-2. PubMed ID: 9891527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer.
    Santala M; Talvensaari-Mattila A; Kauppila A
    Anticancer Res; 2003; 23(3C):3097-103. PubMed ID: 12926169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of flow cytometric DNA analysis in the prognosis of endometrial carcinoma.
    Mangili F; De Marzi P; Di Rocco M; Panacci N; Sassi I
    Eur J Histochem; 1997; 41 Suppl 2():135-6. PubMed ID: 9859818
    [No Abstract]   [Full Text] [Related]  

  • 19. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
    Michels JJ; Marnay J; Plancoulaine B; Chasle J
    Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic index models in stage I and II endometrial carcinoma.
    Nordström B; Bergström R; Strang P
    Anticancer Res; 1998; 18(5B):3717-24. PubMed ID: 9854483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.